BPG is committed to discovery and dissemination of knowledge
Featured Articles
5/5/2024 10:48:17 AM | Browse: 51 | Download: 56
 |
Received |
|
2023-12-27 16:33 |
|
Peer-Review Started |
|
2023-12-27 16:33 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2024-01-16 02:20 |
|
Revised |
|
2024-01-30 21:14 |
|
Second Decision |
|
2024-04-07 01:08 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2024-04-07 07:34 |
|
Articles in Press |
|
2024-04-07 07:34 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2024-04-22 06:37 |
|
Publish the Manuscript Online |
|
2024-05-05 10:11 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247 |
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207 |
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Medicine, General & Internal |
| Manuscript Type |
Editorial |
| Article Title |
Bringing gut microbiota into the spotlight of clinical research and medical practice |
| Manuscript Source |
Invited Manuscript |
| All Author List |
Efstathia Davoutis, Zoi Gkiafi and Panagis M Lykoudis |
| Funding Agency and Grant Number |
|
| Corresponding Author |
Panagis M Lykoudis, MD, MSc, PhD, Lecturer, Division of Surgery and Interventional Science, University College London, Gower Street, London WC1E 6BT, United Kingdom. p.lykoudis@ucl.ac.uk |
| Key Words |
Gut microbiota; Biomarker; Fecal microbiota transplantation; Dysbiosis; Prebiotics |
| Core Tip |
Gut microbiota (GM) serves as a multifaceted tool in healthcare, acting as a potential biomarker, diagnostic, prognostic, and therapeutic entity. While dysbiosis is linked to various diseases, harnessing microbiome's diagnostic potential introduces challenges due to its variability and complex identification techniques. As a prognostic tool, GM provides insights into an individual's health status and disease risks, influencing treatment outcomes. Moreover, it emerges as a therapeutic pathway, with interventions such as prebiotics and fecal microbiota transplantation showing promise. Despite growing recognition, its integration into clinical practice remains limited, necessitating increased research, educational initiatives, and collaborations, to unlock the full potential of GM in advancing patient care. |
| Publish Date |
2024-05-05 10:11 |
| Citation |
Davoutis E, Gkiafi Z, Lykoudis PM. Bringing gut microbiota into the spotlight of clinical research and medical practice. World J Clin Cases 2024; 12(14): 2293-2300 |
| URL |
https://www.wjgnet.com/2307-8960/full/v12/i14/2293.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v12.i14.2293 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
